blenrep
glaxosmithkline (ireland) limited - belantamab mafodotin - szpiczak mnogi - Środki przeciwnowotworowe - blenrep is indicated as monotherapy for the treatment of multiple myeloma in adult patients, who have received at least four prior therapies and whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent, and an anti-cd38 monoclonal antibody, and who have demonstrated disease progression on the last therapy.
tecartus
kite pharma eu b.v. - autologous peripheral blood t cells cd4 and cd8 selected and cd3 and cd28 activated transduced with retroviral vector expressing anti-cd19 cd28/cd3-zeta chimeric antigen receptor and cultured (brexucabtagene autoleucel) - chłoniak, mantle-cell - Środki przeciwnowotworowe - mantle cell lymphomatecartus is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl) after two or more lines of systemic therapy including a bruton’s tyrosine kinase (btk) inhibitor. acute lymphoblastic leukaemiatecartus is indicated for the treatment of adult patients 26 years of age and above with relapsed or refractory b-cell precursor acute lymphoblastic leukaemia (all).
tecvayli
janssen-cilag international n.v. - teclistamab - szpiczak mnogi - Środki przeciwnowotworowe - tecvayli is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.
gamma anty-d 150 150 mcg/ml roztwór do wstrzykiwań
synthaverse s.a. - immunoglobulinum humanum anti-d - roztwór do wstrzykiwań - 150 mcg/ml
gamma anty-d 50 50 mcg/ml roztwór do wstrzykiwań
synthaverse s.a. - immunoglobulinum humanum anti-d - roztwór do wstrzykiwań - 50 mcg/ml
rhophylac 300 300 mcg/2 ml (1500 iu) roztwór do wstrzykiwań
csl behring gmbh - immunoglobulinum humanum anti-d - roztwór do wstrzykiwań - 300 mcg/2 ml (1500 iu)
rhesonativ 625 iu/ml (125 mcg) roztwór do wstrzykiwań
octapharma (ip) sprl - immunoglobulinum humanum anti-d - roztwór do wstrzykiwań - 625 iu/ml (125 mcg)
rhesonativ 750 iu/ml roztwór do wstrzykiwań
octapharma (ip) sprl - immunoglobulinum humanum anti-d - roztwór do wstrzykiwań - 750 iu/ml
metronidazol polpharma 500 mg tabletki
zakłady farmaceutyczne polpharma s.a. - metronidazolum - tabletki - 500 mg
dutrys 0,5 mg kapsułki miękkie
krka, d.d., novo mesto - dutasteridum - kapsułki miękkie - 0,5 mg